指南与共识疼痛医学

慢性疼痛神经刺激指南报告标准依从性评估

Guidelines on neurostimulation for chronic pain: a compliance appraisal of reporting standards.
指南 / 共识 · Reg Anesth Pain Med · 2026-08-05

该研究评估了慢性疼痛神经刺激指南对RIGHT和AGREE报告标准的依从性,纳入24篇指南文章,RIGHT清单平均完成55.12%±12.68%,AGREE清单平均完成52.16%±10.51%。多个方法学领域报告不足,且报告质量与期刊影响因子、发表年份、作者数量或指南主题无显著关联。

要点

  • 慢性疼痛神经刺激指南对RIGHT和AGREE清单的依从性仅约一半,报告质量参差不齐。
  • 报告最不足的领域包括人群特异性考虑、成本/资源影响、指南局限性、推荐制定过程等。
  • 报告质量与期刊影响因子、发表年份、作者数量或指南主题无显著关联。

核心结论

  • 当前慢性疼痛神经刺激指南在报告项目上存在显著差异,关键方法学领域描述明显不足。
  • 对RIGHT和AGREE等既定清单的依从性较差且不一致,这些工具可为未来指南制定提供框架。

研究设计与样本

  • 研究检索了从数据库建立至2024年4月17日的指南文章,纳入24篇关于神经刺激(脊髓刺激、背根神经节刺激、周围神经刺激)治疗慢性疼痛的指南。
  • 主要结局为RIGHT和AGREE清单完成项目的百分比,次要结局包括报告不足的清单项目、报告质量的预测因素及两清单间的一致性。

主要发现

  • RIGHT清单平均完成项目百分比为55.12%±12.68%,AGREE清单为52.16%±10.51%。
  • 最常报告不足(完成率<25%)的主题包括人群特异性考虑、成本/资源影响、指南局限性、推荐制定过程、获益与危害 magnitude 对比、利益冲突声明及管理。
  • RIGHT/AGREE报告质量与期刊影响因子、发表年份、作者数量或指南主题无显著关联。
  • RIGHT与AGREE清单间一致性良好(组内相关系数0.76,95%CI 0.44至0.90)。

关键数值与推荐

  • RIGHT清单平均完成55.12%±12.68%,AGREE清单平均完成52.16%±10.51%。
  • 报告不足项目(完成率<25%)涉及人群特异性考虑、成本/资源影响、指南局限性、推荐制定过程、获益与危害对比、利益冲突管理。
  • 两清单组内相关系数0.76(95%CI 0.44至0.90)。

临床怎么用

  • 麻醉科智能体医生在参考慢性疼痛神经刺激指南时,应注意其方法学报告可能不完整,需谨慎解读推荐意见。
  • 未来指南制定应遵循RIGHT和AGREE清单,加强人群特异性考虑、成本资源、局限性及利益冲突等领域的报告。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The field of neuromodulation has experienced substantial growth, accompanied by an increase in clinical practice guidelines aimed at supporting evidence-based practice. However, adherence to reporting standards remains critical in the development of a comprehensive and transparent clinical practice guideline. This study evaluated the reporting quality of guidelines on neurostimulation for chronic pain by assessing compliance with the Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist and the Appraisal of Guidelines for Research and Evaluation (AGREE) checklist and explored predictors of reporting quality. METHODS: A search strategy was conducted from database inception to April 17, 2024 to identify guideline articles on neurostimulation treatment (spinal cord stimulation, dorsal root ganglion stimulation, peripheral nerve stimulation) for chronic pain. Primary outcomes included the percentage of completed RIGHT and AGREE checklist items. Secondary outcomes included the identification of under-reported checklist items, predictors of reporting quality, and agreement between the two checklists. RESULTS: A total of 24 guideline articles were included, with a mean percentage of completed items being 55.12%±12.68% for the RIGHT checklist and 52.16%±10.51% for the AGREE checklist. Items that were most frequently under-reported (<25% completion) included themes of population-specific considerations, cost/resource implications, guideline limitations, recommendation development process, magnitude of benefit versus magnitude of harm, and statement of competing interests and how they were managed. Secondary analysis revealed no significant associations between RIGHT/AGREE reporting quality and journal impact factor, year of publication, number of authors, or guideline themes. There was good inter-checklist agreement between the RIGHT and AGREE checklists (intraclass correlation coefficient 0.76, 95% CI 0.44 to 0.90), suggesting overlapping but distinct evaluation criteria. CONCLUSIONS: Current guidelines of neurostimulation for chronic pain exhibit significant variability in reporting items, with notable deficiencies in the description of key methodological areas. While adherence to established checklists such as RIGHT and AGREE remains poor and inconsistent, these tools provide a critical framework for enhancing comprehensiveness, transparency, and methodological rigor in future guideline development.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. D'Souza RS, Ege E, McMullin P, et al. Guidelines on neurostimulation for chronic pain: a compliance appraisal of reporting standards. Reg Anesth Pain Med. 2026. PMID: 40623762. doi:10.1136/rapm-2025-106389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。